✦ LIBER ✦

Calcium supplements with vitamin D do not increase risk of cardiovascular diseases: Results from a randomized controlled trial

✍ Scribed by L. Rejnmark; P. Vestergaard; L. Mosekilde

Book ID: 116324236
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 48 KB
Volume: 48
Category: Article
ISSN: 8756-3282
DOI: 10.1016/j.bone.2011.03.092

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized controlled trial of calcium

A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease

✍ Thomas E. Rohan; Abdissa Negassa; Rowan T. Chlebowski; Clementina D. Ceria-Ulep; 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 245 KB

Vitamin D does not improve the metabolic

Vitamin D does not improve the metabolic health of patients with chronic kidney disease stage 3-4: A randomized controlled trial

✍ Petchey, William G; Hickman, Ingrid J; Prins, Johannes B; Hawley, Carmel M; John 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 662 KB

The VITamin D and OmegA-3 TriaL (VITAL):

The VITamin D and OmegA-3 TriaL (VITAL): Rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease

✍ JoAnn E. Manson; Shari S. Bassuk; I-Min Lee; Nancy R. Cook; Michelle A. Albert; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 521 KB

Echinacea purpurea along with zinc, sele

Echinacea purpurea along with zinc, selenium and vitamin C to alleviate exacerbations of chronic obstructive pulmonary disease: results from a randomized controlled trial

✍ F. Isbaniah; W. H. Wiyono; F. Yunus; A. Setiawati; U. Totzke; M. A. Verbruggen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 292 KB

Alendronate/vitamin D3 70 mg/2800 IU wit

Alendronate/vitamin D3 70 mg/2800 IU with and without additional 2800 IU vitamin D3 for osteoporosis: Results from the 24-week extension of a 15-week randomized, controlled trial

✍ Neil Binkley; Johann D. Ringe; John I. Reed; Östen Ljunggren; Michael F. Holick; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 511 KB

The vitamin D analogue 2MD increases bon

The vitamin D analogue 2MD increases bone turnover but not BMD in postmenopausal women with osteopenia: Results of a 1-year phase 2 double-blind, placebo-controlled, randomized clinical trial

✍ Hector F DeLuca; Wendy Bedale; Neil Binkley; J Chris Gallagher; Michael Bolognes 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 215 KB 👁 1 views

## Abstract Most osteoporosis drugs act by inhibiting bone resorption. A need exists for osteoporosis therapies that stimulate new bone formation. 2‐Methylene‐19‐nor‐(20__S__)‐1α,25‐dihydroxyvitamin D~3~ (2MD) is a vitamin D analogue that potently stimulates bone formation activity in vitro and in